Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 531278 | NSE Symbol : | ISIN : INE785D01012 | Industry : Finance & Investments |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
28-Mar-2025	28-Mar-2025	Change in Directors	Enclosed is an intimation for change in Directors
31-Jan-2025	07-Feb-2025	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve standalone and consolidated un-audited financial results for the quarter and nine months ended 31-Dec-2024 Enclosed is the un-audited financial results (standalone and consolidated) for the quarter and nine months ended 31-Dec-2024.
07-Nov-2024	13-Nov-2024	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2024 Enclosed is outcome of Board Meeting held on 13-Nov-2024, together with standalone and consolidated un-audited financial results for the quarter and half year ended 30-Sep-2024 (As per BSE Announcement Dated on 13/11/2024)
15-Oct-2024	15-Oct-2024	Change in Directors	Change in designation of Mrs. Radhika Mehta as Whole Time Director & CFO of the Company to Whole Time Director of the Company w.e.f. 15th October, 2024. Detailed disclosure is enclosed.
31-Jul-2024	13-Aug-2024	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the un-audited (standalone and consolidated) financial results for the quarter ended 30th June 2024 Enclosed are the standalone and consolidated un-audited financial results for the quarter ended 30th June, 2024 (As Per BSE Announcement Dated on: 13/08/2024)
07-May-2024	16-May-2024	Final Dividend	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve standalone and consolidated audited financial results for the financial year ended 31st March 2024 and other items of business as stated in the enclosed intimation Enclosed is an intimation regarding declaration of final dividend Enclosed is the Outcome of Board Meeting together with Standalone and Consolidated Audited Annual Financial Results for the quarter and year ended 31st March, 2024 (As Per BSE Announcement Dated on 16.05.2024) We hereby re-submit the audited standalone and consolidated annual financial results for the quarter and financial year ended 31st March, 2024. In the earlier results submitted on 16th May, 2024, after its approval in the Board Meeting, the figures for the previous quarter ended 31st December, 2023 were inadvertantly not mentioned. We re-submit the standalone and consolidated results with a column mentioning the figures for the previous quarter ended 31st December, 2023. Inconvenience is regretted. Read less.. (As Per BSE Announcement Dated on 28.05.2024)
21-Mar-2024	21-Mar-2024	Change in Directors	The Board of Directors at its meeting held on 21st March, 2024 approved the appointment of Mr. Shail Kapadia as an Independent Director for a term of 5 years w.e.f. 1st April, 2024. Mr. Dilip Kapadia will be completing his second term of Independent Director on 31st March, 2024. Accordingly, he shall cease to be an Independent Director of the Company.
02-Feb-2024	13-Feb-2024	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the un-audited financial results for the quarter and nine months ended 31st December 2023 Enclosed is the quarterly un-audited financial results (standalone and consolidated) for the quarter and nine months ended 31st December, 2023. The same has been approved at the Board Meeting of the Company held on 13th February, 2024. (As per BSE Announcement Dated on 13/02/2024)
30-Oct-2023	09-Nov-2023	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve standalone and consolidated un-audited financial results for the quarter and half year ended 30th September 2023 Find enclosed standalone and consolidated un-audited financial results for the quarter and half year ended 30th September, 2023 adopted by the Board at its meeting held on 9th November, 2023. (As per BSE Announcement Dated on 09/11/2023) Enclosed are the un-audited financial results (standalone and consolidated) for the quarter and half year ended 30th September, 2023 approved by the Board at its meeting held on November 9, 2023. There is no revision in the results. The results are being re-submitted as a reply to the query raised by BSE Limited wherein the designation of the person signing the results have been indicated. (As Per BSE Announcement Dated on 12.12.2023)
20-Jul-2023	11-Aug-2023	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2023 The Board Meeting of the Company was held on 11th August, 2023. The Board of Directors at its meeting have approved and taken on record the un-audited financial results (standalone and consolidated) for the quarter ended June 30, 2023. Find enclosed the said results alongwith limited review reports in respect of the same. (As Per BSE Announcement Dated on 11.08.2023)
19-May-2023	30-May-2023	Accounts	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March 2023 and To consider and recommend Dividend if any The Board Meeting of the Company was held on 30th May, 2023. The Board of Directors at their Board Meeting have recommended Final Dividend of 12.5% (Re. 1.25 per equity share) for the financial year ended 31st March, 2023 subject to approval of the shareholders at the 29th Annual General Meeting. The information is being filed pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. The Board Meeting of the Company was held on 30th May, 2023. The Board of Directors at the Board Meeting of the Company have approved the following: a. Approved and taken on record the Audited Annual Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2023. b. The Board recommended final dividend @ 12.5% (Rs. 1.25 per equity share) for the financial year ended 31st March, 2023 subject to approval of the shareholders at the 29th Annual General Meeting. Please find enclosed herewith the following: 1. Audited Annual Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2023. 2. Statement of Assets and Liabilities as on 31st March, 2023. (Standalone and Consolidated) 3. Statement of Cash Flow for the financial year ended 31st March, 2023. (Standalone and Consolidated) 4. Audit Report for the financial year ended 31st March, 2023. (Standalone and Consolidated) (As Per BSE Announcement dated on 30.05.2023)
14-Jan-2023	30-Jan-2023	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2022. The Company has already intimated to the Exchange on 31st December 2022 that the trading window for dealing in securities of the Company shall remain closed from Sunday 01st January 2023 for the consideration of Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2022. The trading window will open 48 hours after the declaration of the said Un-Audited Financial Results The Board Meeting of the Company was held on 30th January, 2023. The Board of Directors at the Board Meeting of the Company have approved and taken on record the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022. Please find enclosed herewith the following: 1. Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022. 2. Limited Review Report for the quarter and nine months ended 31st December, 2022. The information and papers are being filed pursuant to Regulation 33(3) of the SEBI (LODR) Regulations, 2015. The Meeting of the Board of Directors commenced at 04.00 p.m. and concluded at 5.25 p.m. (As Per BSE Announcement dated on 30.01.2023)
07-Oct-2022	17-Oct-2022	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2022 inter alia to consider and approve Pursuant to Regulation 29 (1) (a) of the SEBI (LODR) Regulations 2015 Notice is hereby given that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday 17th October 2022 at 03.00 p.m. at the Registered Office of the Company inter-alia to consider and approve the following: 1. Approve and take on record the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2022. 2. To consider any other business with the permission of the Chair. Disclosure of Trading Window: The Company has already intimated to the Exchange on 30th September 2022 that the trading window for dealing in securities of the Company shall remain closed from Saturday 01st October 2022 for the consideration of Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2022. The trading window will open 48 hours after the declaration of the said Un-Audited Financial Results. The Board Meeting of the Co. was held on 17th October, 2022. The Board at its Meeting had approved and taken on record the Un-Audited Financial Results (Standalone & Consol.) for the quarter & half year ended 30th September, 2022. The said results were filed with BSE Limited on 17th October, 2022. However inadvertantly, the date of Board Meeting in the notes to financial results filed in .pdf format was mentioned as 18th October, 2022 instead of 17th October, 2022. In this regard, find enclosed the revised Un-Audited Financial Results (Standalone & Consol.) for the quarter & half year ended 30th September, 2022 with the correct date of Board Meeting i.e. 17th October, 2022 together with the other attachments. There is no other change in the financial results and its attachments. Further, the results filed in xbrl format on 17th October, 2022 had the correct date of Board Meeting, accordingly, the same is not filed again. (As Per BSE Announcement Dated on 31.10.2022)
08-Jul-2022	18-Jul-2022	Quarterly Results	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2022 inter alia to consider and approve Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 301h June 2022. Disclosure of Trading Window: The Company has already intimated to the Exchange on 30th June 2022 that the trading window for dealing in securities of the Company shall remain closed from Friday 01 st July 2022 for the consideration of Un-Audited Financial Results of the Company for the quarter ended 30th June 2022. The trading window will open 48 hours after the declaration of the said Un-Audited Financial Results. The Board Meeting of the Company was held on 18th July, 2022. The Board of Directors at the Board Meeting of the Company have approved and taken on record the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2022. Please find enclosed herewith the following: 1. Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2022. 2. Limited Review Report for the quarter ended 30th June, 2022. The information and papers are being filed pursuant to Regulation 33(3) of the SEBI (LODR) Regulations, 2015. The Meeting of the Board of Directors commenced at 02.00 p.m. and concluded at 3.30 p.m. (As per BSE Announcement Dated on 18/07/2022)
09-May-2022	26-May-2022	Final Dividend	Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 inter alia to consider and approve Pursuant to Regulation 29 (1) (a) & (e) of the SEBI (LODR) Regulations 2015 Notice is hereby given that the Meeting of the Board of Directors of the Company is scheduled to be held on Thursday 26th May 2022 at 03.00 p.m. at the Registered Office of the Company inter-alia to consider and approve the following: 1. Approve and take on record the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March 2022. 2. To consider and recommend the Dividend if any. Disclosure of Trading Window: The Company has already intimated to the Exchange on 31st March 2022 that the trading window for dealing in securities of the Company shall remain closed from Friday 01st April 2022 for the consideration of Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended 31st March 2022. The trading window will open 48 hours after the declaration of the said Audited Financial Results. The Board Meeting of the Company was held on 26th May, 2022. The Board of Directors at their Board Meeting recommended Final Dividend of 12.50% (Rs. 1.25 per equity share) for the financial year ended 31st March, 2022 subject to approval of the shareholders at the 28th Annual General Meeting. The information is being filed pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. Please take the aforesaid on your records and acknowledge the receipt. The Board Meeting of the Company was held on 26th May, 2022. The Board of Directors at the Board Meeting of the Company have approved and taken on record the Audited Annual Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2022. Please find enclosed herewith the following: 1. Audited Annual Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2022. 2. Statement of Assets and Liabilities as on 31st March, 2022. 3. Statement of Cash Flow for the financial year ended 31st March, 2022. 4. Audit Report for the financial year ended 31st March, 2022. 5. The Board recommended the final dividend of 12.50% (Rs. 1.25 per equity share) for the financial year ended 31st March, 2022 subject to approval of the shareholders at the 28th Annual General Meeting. 6. Appointment of Mr. Dipan Mehta as Non-Executive Chairman w.e.f. 01st June, 2022. The Board Meeting of the Company was held on 26th May, 2022. As per the recommendation of Nomination and Remuneration Committee and on expiry of present term of Mr. Dipan Mehta as Chairman and Whole-Time Director on 31st May, 2022, the Board of Directors at their Board Meeting appointed Mr. Dipan Mehta as Non-Executive Chairman of the Company w.e.f. 01st June, 2022. The information is being filed pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. Please take the aforesaid on your records and acknowledge the receipt. (As Per BSE Announcement Dated on 26.05.2022)

1 2

LOGIN HERE

Elixir Capital Ltd

Board Meeting